Evidence map›Paper›PMID 41028129›Full record

ArticleScientific reports2025

Attention-enhanced hybrid U-Net for prostate cancer grading and explainability.

Ahmad Nawaz Zaheer, Muhammad Farhan, Guilin Min, Faiz Abdullah Alotaibi, Mrim M Alnfiai

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ahmad Nawaz ZaheerBOYA International College, Jiangxi University of Technology, 115 Ziyang Avenue, Nanchang, 330022, Jiangxi, China. alpha@jxut.edu.cn.
Muhammad Farhan *Department of Computer Science, COMSATS University Islamabad, Sahiwal Campus, Sahiwal, Pakistan.
Guilin Min *BOYA International College, Jiangxi University of Technology, 115 Ziyang Avenue, Nanchang, 330022, Jiangxi, China.
Faiz Abdullah AlotaibiDepartment of Information Science, College of Humanities and Social Sciences, King Saud University, Riyadh, Saudi Arabia.
Mrim M AlnfiaiDepartment of Information Technology, College of Computers and Information Technology, Taif University, P.O. Box 11099, 21944, Taif, Saudi Arabia.

Funding

Taif University, Saudi Arabia TU-DSPP-2024-41
6 · The paper itself

Abstract

Prostate cancer remains a leading cause of mortality, necessitating precise histopathological segmentation for accurate Gleason Grade assessment. However, existing deep learning-based segmentation models lack contextual awareness and explainability, leading to inconsistent performance across heterogeneous tissue structures. Conventional U-Net architectures and CNN-based approaches struggle with capturing long-range dependencies and fine-grained histopathological patterns, resulting in suboptimal boundary delineation and model generalizability. To address these limitations, we propose a transformer-attention hybrid U-Net (TAH U-Net), integrating hybrid CNN-transformer encoding, attention-guided skip connections, and a multi-stage guided loss mechanism for enhanced segmentation accuracy and model interpretability. The ResNet50-based convolutional layers efficiently capture local spatial features, while Vision Transformer (ViT) blocks model global contextual dependencies, improving segmentation consistency. Attention mechanisms are incorporated into skip connections and decoder pathways, refining feature propagation by suppressing irrelevant tissue noise while enhancing diagnostically significant regions. A novel hierarchical guided loss function optimizes segmentation masks at multiple decoder stages, improving boundary refinement and gradient stability. Additionally, Explainable AI (XAI) techniques such as LIME, Occlusion Sensitivity, and Partial Dependence Analysis (PDP), validate the model's decision-making transparency, ensuring clinical reliability. The experimental evaluation on the SICAPv2 dataset demonstrates state-of-the-art performance, surpassing traditional U-Net architectures with a 4.6% increase in Dice Score, 5.1% gain in IoU, along with notable improvements in Precision (+ 4.2%) and Recall (+ 3.8%). This research significantly advances AI-driven prostate cancer diagnostics by providing an interpretable and highly accurate segmentation framework, enhancing clinical trust in histopathology-based grading within medical imaging and computational pathology.

Indexed as

Prostatic NeoplasmsDeep LearningHumansMaleNeoplasm GradingNeural Networks, ComputerExplainable AI (XAI)Gleason grade classificationHistopathology imagingMulti-stage guided lossProstate cancer segmentationTransformer-attention hybrid U-Net

Identifiers

PMID41028129
PMCPMC12485157

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.